Recovery act tissue samples and data from various types of cancer for the cancer genome atlas (tcga) program arra::yes::arra
Ended Awarded Last action
- Contract number
- HHSN261201000051I
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $143,588 obligated
Award facts
- Opportunity
-
- RECOVERY- Tissue Purchase Order Contract Acquisition for NCI's The Cancer Genome Atlas Program Award Notice · Posted Dec 4, 2009
- Combined order value
- $143,588 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 46% used
- $315,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency, to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated. The $315,000 contract provides tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program, with a period of performance through March 31, 2015. The contract is funded through the American Recovery and Reinvestment Act (ARRA) and does not have a small business set-aside designation.
Under this IDC, the NCI has issued at least one $143,587.50 firm fixed-price delivery order to Brigham & Women's Hospital to support the TCGA program. This allows the NCI to efficiently procure specialized genomic research services from an experienced provider to advance its precision medicine initiatives. As a subsidiary of a major healthcare system, Brigham & Women's Hospital has significant expertise in areas like oncology and has received numerous federal contract and grant awards to conduct cutting-edge biomedical and clinical research.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Recovery act tissue samples and data from various types of cancer for the cancer genome atlas (tcga) program… | National Cancer Institute (NIH) | $143,588 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201000051I?
HHSN261201000051I was awarded to Brigham & Womens Hospital Inc. by National Cancer Institute (National Institutes of Health) on June 23, 2010.
How much is contract HHSN261201000051I worth?
Orders under HHSN261201000051I have obligated $143,588. HHSN261201000051I's own ceiling is $315,000.
How many orders have been placed under contract HHSN261201000051I?
1 order has been placed under HHSN261201000051I, the latest on June 23, 2010.
Who can order from contract HHSN261201000051I?
HHSN261201000051I is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201000051I part of a contract vehicle?
Yes. HHSN261201000051I is part of NCI Cancer Genome Atlas Program Tissue Purchase.
Was contract HHSN261201000051I competed?
The extent of competition for HHSN261201000051I was competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV